Vitexicarpin induces apoptosis in human prostate carcinoma PC-3 cells through G2/M phase arrest

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 12, 2012, Pages 6369-6374

  Meng, Fan Min ^a   Yang, Jing Bo ^b   Yang, Chun Hui ^c   Jiang, Yu ^a   Zhou, Yong Feng ^a   Yu, Bo ^a   Yang, Hong ^a  

^a LIAONING NORMAL UNIVERSITY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

3 cells; Anticancer; Apoptosis; G2 M phase arrest; PC; Vitexicarpin

Indexed keywords

CASTICIN; CYTOCHROME C; FLAVONOID; PLANT EXTRACT; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CARCINOMA; CELL CYCLE CHECKPOINT; CELL CYCLE G2 PHASE; CELL DEATH; CELL DIVISION; CHINESE MEDICINE; DOWN REGULATION; DRUG EFFECT; GENETICS; HUMAN; MALE; METHODOLOGY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; PROSTATE TUMOR; TUMOR CELL LINE; UPREGULATION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA; CELL CYCLE CHECKPOINTS; CELL DEATH; CELL DIVISION; CELL LINE, TUMOR; CYTOCHROMES C; DOWN-REGULATION; FLAVONOIDS; G2 PHASE; HUMANS; MALE; MEDICINE, CHINESE TRADITIONAL; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; PLANT EXTRACTS; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; UP-REGULATION;

EID: 84877095072     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.12.6369     Document Type: Article

References (27)

1. Antico Arciuch VG, Elguero ME, Poderoso JJ, et al (2012). Mitochondrial regulation of cell cycle and proliferation. Antioxid Redox Sign, 16, 1150-80.
2. Batsi C, Markopoulou S, Kontargiris E, et al (2009). Bcl-2 blocks 2-methoxyestradiol induced leukemia cell apoptosis by a p27(Kip1)-dependent G1/S cell cycle arrest in conjunction with NF-kappaB activation. Biochem Pharmacol, 78, 33-44.
3. Chen D, Cao J, Tian L, et al (2011). Induction of apoptosis by casticin in cervical cancer cells through reactive oxygen species-mediated mitochondrial signaling pathways. Oncol Rep, 26, 1287-94.
4. Choudhary MI, Azizuddin, Jalil S, et al (2009). Antiinflammatory and lipoxygenase inhibitory compounds from Vitex agnus-castus. Phytother Res, 23, 1336-9.
5. De Luca V, Salim V, Atsumi SM, et al (2012). Mining the biodiversity of plants: a revolution in the making. Science, 336, 1658-61.
6. Enomoto M, Goto H, Tomono Y, et al (2009). Novel positive feedback loop between Cdk1 and Chk1 in the nucleus during G2/M transition. J Biol Chem, 284, 34223-30.
7. Gavet O, Pines J (2010). Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. Dev Cell, 18, 533-43.
8. Giono LE, Manfredi JJ (2006). The p53 tumor suppressor participates in multiple cell cycle checkpoints. J Cell Physiol, 209, 13-20.
9. Gottlieb RA (2001). Mitochondria and apoptosis. Biol Signal Recept, 10, 147-61.
10. He L, Yang X, Cao X, et al (2012). Casticin induces growth suppression and cell cycle arrest through activation of FOXO3a in hepatocellular carcinoma. Oncol Rep, 29, 103-8.
11. Ji YB, Qu ZY, and Zou X (2011). Juglone-induced apoptosis in human gastric cancer SGC-7901 cells via the mitochondrial pathway. Exp Toxicol Pathol, 63, 69-78.
12. Khan M, Ding C, Rasul A, et al (2012). Isoalantolactone induces reactive oxygen species mediated apoptosis in pancreatic carcinoma PANC-1 cells. Int J Biol Sci, 8, 533-47.
13. Khan M, Zheng B, Yi F, et al (2012). Pseudolaric Acid B induces caspase-dependent and caspase-independent apoptosis in u87 glioblastoma cells. Evid-Based Complalt, Article ID 957568.
14. Koh DJ, Ahn HS, Chung HS, et al (2011). Inhibitory effects of casticin on migration of eosinophil and expression of chemokines and adhesion molecules in A549 lung epithelial cells via NF-κB inactivation. J Ethnopharmacol, 136, 399-405.
15. Komata T, Kanzawa T, Takeuchi H, et al (2003). Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells. Brit J Cancer, 88, 1277-80.
16. Maddika S, Ande SR, Panigrahi S, et al (2007). Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist Updat, 10, 13-29.
17. Mesaik MA, Azizuddin, Murad S, et al (2009). Choudhary MI. Isolation and immunomodulatory properties of a flavonoid, casticin from Vitex agnus-castus. Phytother Res, 23, 1516-20.
18. Mishra BB, Tiwari VK (2011). Natural products: an evolving role in future drug discovery. Eur J Med Chem, 46, 4769-807.
19. Mondal S, Bandyopadhyay S, Ghosh MK, et al (2012). Natural products: promising resources for cancer drug discovery. Anti-cancer Agent Me, 12, 49-75.
20. Muschel RJ, McKenna WG (1996). Alterations in cell cycle control during tumor progression: effects on apoptosis and the response to therapeutic agents. Curr Top Microbiol, 213, 197-213.
21. Prostate Cancer Overview. American Cancer Society, 02/27/2012.
22. Schafer KA (1998). The cell cycle: a review. Vet Pathol, 35, 461-78.
23. Schultz DR, Harrington WJ Jr (2003). Apoptosis: programmed cell death at a molecular level. Semin Arthritis Rheu, 32, 345-69.
24. Shen JK, Du HP, Yang M, et al (2009). Casticin induces leukemic cell death through apoptosis and mitotic catastrophe. Ann Hematol, 88, 743-52.
25. Yang J, Yang Y, Tian L, et al (2011). Casticin-induced apoptosis involves death receptor 5 upregulation in hepatocellular carcinoma cells. World J Gastroentero, 17, 4298-307.
26. Zeng F, Tian L, Liu F, et al (2012). Induction of apoptosis by casticin in cervical cancer cells: reactive oxygen species-dependent sustained activation of Jun N-terminal kinase. Acta Bioch Bioph Sin, 44, 442-9.
27. Zinkel S, Gross A, Yang E (2006). BCL2 family in DNA damage and cell cycle control. Cell Death Differ, 13, 1351-9.